Finance

Beta
Lists
CRDL:TSE
Cardiol Therapeutics Inc
CA$1.51
0.00%
(0.00) 1D
Jun 26, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CRDL...
Open
CA$1.52
High
CA$1.52
Low
CA$1.47
Mkt. cap
174.02M
Avg. vol.
45.16K
Volume
22.18K
52-wk high
CA$2.33
52-wk low
CA$1.22
EPS
-CA$0.39
Beta
0.59
Shares outstanding
115.27M
No. of employees
18
Open
CA$1.52
High
CA$1.52
Low
CA$1.47
Mkt. cap
174.02M
Avg. vol.
45.16K
Volume
22.18K
52-wk high
CA$2.33
52-wk low
CA$1.22
EPS
-CA$0.39
Beta
0.59
Shares outstanding
115.27M
No. of employees
18
News stories
From sources across the web
About Cardiol Therapeutics Inc
CEODavid Elsley
Employees18
Founded2017
HeadquartersOakville, Ontario, Canada
SectorPharmaceutical industry
Websitecardiolrx.com
Last report
May 11, 2026
Fiscal period
Q1 2026
EPS / Est. (CAD)
-CA$0.10 / -CA$0.09
-11.11%miss
Revenue / Est. (CAD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.73M
4.79M
2.74M
4.95M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.94M
5.39M
5.29M
4.76M
Operating expense
7.68M
10.18M
8.03M
9.71M
Total operating expenses
7.68M
10.18M
8.03M
9.71M
Operating income
-7.68M
-10.18M
-8.03M
-9.71M
Other non operating income
-
-
951.74K
-1.53M
EBT including unusual items
-8.35M
-9.96M
-7.21M
-10.82M
EBT excluding unusual items
-8.35M
-9.96M
-7.21M
-10.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.35M
-9.96M
-7.21M
-10.82M
Net profit margin
-
-
-
-
Earnings per share
-0.10
-0.12
-0.07
-0.10
Interest and investment income
180.67K
122.26K
175.21K
200.72K
Interest expense
-
-
-
-
Net interest expenses
180.67K
122.26K
175.21K
200.72K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.67M
-10.17M
-8.02M
-9.70M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of CRDL
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer